Toward an immune-mediated subtype of autism spectrum disorder

Brain Research

Volumn 1617, Issue , 2015, Pages 72-92

  McDougle, Christopher J ^a,d   Landino, Samantha M ^b,c   Vahabzadeh, Arshya ^a,c,d   O'Rourke, Julia ^a,d   Zurcher, Nicole R ^a,d   Finger, Beate C ^b,c,d   Palumbo, Michelle L ^a,d   Helt, Jessica ^a   Mullett, Jennifer E ^a   Hooker, Jacob M ^a,d   Carlezon, William A ^b,c,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Behavioral Genetics Laboratory   (United States)

^c MCLEAN HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Animal models; Autism spectrum disorder; Autoimmune disorders; Immunology; Neuroimaging; Pathophysiology; Post mortem; Psychopharmacology

Indexed keywords

ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; CELECOXIB; CORTICOSTEROID; CORTICOTROPIN; ENDOTOXIN; HUMAN IMMUNOGLOBULIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; LENALIDOMIDE; NEUROLEPTIC AGENT; PENTOXIFYLLINE; PIOGLITAZONE; POLYINOSINIC POLYCYTIDYLIC ACID; PREGNENOLONE; SPIRONOLACTONE; VALPROIC ACID; ANTIINFLAMMATORY AGENT; INTERFERON INDUCING AGENT;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTISM; AUTOIMMUNE DISEASE; AUTOIMMUNITY; AUTOPSY; BEHAVIOR ASSESSMENT; BRAIN ELECTROPHYSIOLOGY; BRAIN REGION; CLINICAL STUDY; CLINICAL TRIAL (TOPIC); CONTROLLED CLINICAL TRIAL (TOPIC); CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; FAMILIAL DISEASE; FAMILY STUDY; GENETIC MODEL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NEUROCHEMISTRY; NEUROIMAGING; NEUROPATHOLOGY; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PHARMACOLOGICAL PROCEDURES; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGENY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK FACTOR; SOCIAL BEHAVIOR; SOCIAL INTERACTION TEST; STUDY; ANIMAL; AUTISM SPECTRUM DISORDER; BRAIN; COMPLICATION; DISEASE MODEL; ENCEPHALITIS; GENETICS; IMMUNOLOGY; INFLAMMATION; PATHOLOGY;

ANIMALIA;

ANIMALS; ANTI-INFLAMMATORY AGENTS; AUTISM SPECTRUM DISORDER; AUTOIMMUNE DISEASES; BRAIN; DISEASE MODELS, ANIMAL; ENCEPHALITIS; HUMANS; INFLAMMATION; INTERFERON INDUCERS;

EID: 84937635203     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2014.09.048     Document Type: Review

References (137)

1. A. Aguzzi, B.A. Barres, and M.L. Bennett Microglia: scapegoat, saboteur, or something else? Science 339 6116 2013 156 161 10.1126/science.1227901
2. S. Akhondzadeh, J. Fallah, MR. Mohammadi, R. Imani, M. Mohammadi, B. Salehi, A. Ghanizadeh, M. Raznahan, S. Mohebbi-Rasa, SA. Rezazadeh, and S. Forghani Double-blind, placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism Prog. Neuropsychopharmacol. Biol. Psychiatry 34 1 2010 32 36 10.1016/j.pnpbp.2009.09.012
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders fourth ed. revised 2000 American Psychiatric Press Washington, DC
4. M. Asadabadi, M.R. Mohammadi, A. Ghanizadeh, M. Ashrafi, E. Hassanzadeh, S. Forghani, and S. Akhondzadeh Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial Psychopharmacology (Berlin) 225 1 2013 51 59 10.1007/s00213-012-2796-8
5. P. Ashwood, and J. Van de Water A review of autism and the immune response Clin. Dev. Immunol. 11 2 2004 165 174 10.1080/10446670410001722096
6. H.O. Atladóttir, M.G. Pedersen, P. Thorsen, P.B. Mortensen, B. Deleuran, W.W. Eaton, and E.T. Parner Association of family history of autoimmune diseases and autism spectrum disorders Pediatrics 124 2 2009 687 694 10.1542/peds.2008-2445
7. T.L. Arndt, C.J. Stodgell, and P.M. Rodier The teratology of autism Int. J. Dev. Neurosci. 23 2-3 2005 189 199 10.1016/j.ijdevneu.2004.11.001
8. M. Baharnoori, W.G. Brake, and L.K. Srivastava Prenatal immune challenge induces developmental changes in the morphology of pyramidal neurons of the prefrontal cortex and hippocampus in rats Schizophr. Res. 107 1 2009 99 109 10.1016/j.schres.2008.10.003
9. 3H]PK11195 binding to activated microglia J. Neurocytol. 26 2 1997 77 82 10.1023/A:1018567510105
10. R.B. Banati Visualising microglial activation in vivo Glia 40 2 2002 206 217 10.1002/glia.10144
11. R.B. Banati Neuropathological imaging: in vivo detection of glial activation as a measure of disease and adaptive change in the brain Br. Med. Bull. 65 1 2003 121 131 10.1093/bmb/65.1.121
12. M. Bauman, and T.L. Kemper Histoanatomic observations of the brain in early infantile autism Neurology 35 6 1985 866 874 10.1212/WNL.35.6.866
13. M.D. Bauman, A.M. Iosif, P. Ashwood, D. Braunschweig, A. Lee, C.M. Schumann, J. Van de Water, and D.G. Amaral Maternal antibodies from mothers of children with autism alter brain growth and social behavior development in the rhesus monkey Transl. Psychiatry 3 2013 e278 10.1038/tp.2013.47
14. M.D. Bauman, A.M. Iosif, S.E. Smith, C. Bregere, D.G. Amaral, and P.H. Patterson Activation of the maternal immune system during pregnancy alters behavioral development of rhesus monkey offspring Biol. Psychiatry 75 4 2014 332 341 10.1016/j.biopsych.2013.06.025
15. P.B. Beeson Age and sex associations of 40 autoimmune diseases Am. J. Med. 96 5 1994 457 462 10.1016/0002-9343(94)90173-2
16. K. Bendtzen, P.R. Hansen, K. Rieneck Sprionolactone/Arthritis Study Group Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-alpha and interferon-gamma, and has potential in the treatment of arthritis Clin. Exp. Immunol. 134 1 2003 151 158 10.1046/j.1365-2249.2003.02249.x
17. M. Boris, A. Goldblatt, and S.M. Edelson Improvement in children with autism treated with intravenous gamma globulin J. Nutr. Environ. Med 15 4 2006 1 8 10.1080/13590840600681827
18. M. Boris, C.C. Kaiser, A. Goldblatt, M.W. Elice, S.M. Edelson, J.B. Adams, and D.L. Feinstein Effect of pioglitazone treatment on behavioral symptoms in autistic children J. Neuroinflamm 4 2007 3 10.1186/1742-2094-4-3
19. J. Borrell, J.M. Vela, A. Arévalo-Martin, E. Molina-Holgado, and C. Guaza Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophrenia Neuropsychopharmacology 26 2 2002 204 215 10.1016/S0893-133X(01)00360-8
20. J.J. Bradstreet, S. Smith, D. Granpeesheh, J.M. El-Dahr, and D. Rossignol Spironolactone might be a desirable immunologic and hormonal intervention in autism spectrum disorders Med. Hypotheses 68 5 2007 979 987 10.1016/j.mehy.2006.10.015
21. D. Braunschweig, M.S. Golub, C.M. Koenig, L. Qi, I.N. Pessah, J. Van de Water, and R.F. Berman Maternal autism-associated IgG antibodies delay development and produce anxiety in a mouse gestational transfer model J. Neuroimmunol. 252 1-2 2012 56 65 10.1016/j.jneuroim.2012.08.002
22. A.K. Brown, M. Fujita, Y. Fujimura, J.S. Liow, M. Stabin, Y.H. Ryu, M. Imaizumi, J. Hong, V.W. Pike, and R.B. Innis Radiation dosimetry and biodistribution in monkey and man of 11C-PBR28: a PET radioligand to image inflammation J. Nucl. Med. 48 12 2007 2072 2079 10.2967/jnumed.107.044842
23. J.K. Buitelaar, H. van Engeland, J.M. van Ree, and D. de Wied Behavioral effects of Org 2766, a synthetic analog of the adrenocorticotrophic hormone (4-9), in 14 outpatient autistic children J. Autism Dev. Disord. 20 4 1990 467 478 10.1007/BF02216053
24. J.K. Buitelaar, H. van Engeland, K. de Kogel, H. de Vries, J. van Hooff, and J.M. van Ree The adrenocorticotrophic hormone (4-9) analog ORG 2766 benefits autistic children: report on a second controlled clinical trial J. Am. Acad. Child Adolesc. Psychiatry 31 6 1992 1149 1156 10.1097/00004583-199211000-00026
25. J.K. Buitelaar, H. van Engeland, K.H. de Kogel, H. de Vries, J.A. van Hooff, and J.M. van Ree The use of adrenocorticotrophic hormone (4-9) analog ORG 2766 in autistic children: effects on the organization of behavior Biol. Psychiatry 31 11 1992 1119 1129 10.1016/0006-3223(92)90156-T
26. Z. Cai, Z.L. Pan, Y. Pang, O.B. Evans, and P.G. Rhodes Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration Pediatr. Res. 47 1 2000 64 72 10.1203/00006450-200001000-00013
27. F. Cao, A. Yin, G. Wen, A.M. Sheikh, Z. Taugeer, M. Malik, A. Nagori, M. Schirripa, F. Schirripa, G. Merz, W.T. Brown, and X. Li Alteration of astrocytes and Wnt/ß-catenin signaling in the frontal cortex of autistic subjects J. Neuroinflamm 9 1 2012 223 10.1186/1742-2094-9-223
28. M.G. Chez, M. Loeffel, C.P. Buchanan, and M. Field-Chez Pulse high dose steroids as combination therapy with valproic acid in epileptic aphasia patients with pervasive developmental delay or autism Ann. Neurol 44 3 1998 539
29. M. Chez, R. Low, C. Parise, and T. Donnel Safety and observations in a pilot study of lenalidomide for treatment in autism Autism Res. Treat 2012 2012 291601 10.1155/2012/291601
30. A.M. Comi, A.W. Zimmerman, V.H. Frye, P.A. Law, and J.N. Peeden Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism J. Child Neurol. 14 6 1999 388 394 10.1177/088307389901400608
31. L.A. Croen, J.K Grether, C.K. Yoshida, R. Odouli, and J. Van de Water Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study Arch. Pediatr. Adolesc. Med. 159 2 2005 151 157 10.1001/archpedi.159.2.151
32. P. Dalton, R. Deacon, A. Blamire, M. Pike, I. McKinlay, J. Stein, P. Styles, and A. Vincent Maternal neuronal antibodies associated with autism and a language disorder Ann. Neurol. 53 2003 533 537
33. G. DelGiudice-Asch, L. Simon, J. Schmeidler, C. Cunningham-Rundles, and E. Hollander Brief report: a pilot open clinical trial of intravenous immunoglobulin in childhood autism J. Autism Dev. Disord. 29 2 1999 157 160 10.1023/A:1023096728131
34. J. De Miranda, K. Yaddanapudi, M. Hornig, G. Villar, R. Serge, and W.I. Lipkin Induction of toll-like receptor 3-mediated immunity during gestation inhibits cortical neurogenesis and causes behavioral disturbances mBio. 1 4 2010 e00176 10 10.1128/mBio.00176-10 (pii)
35. C.T. Deshmukh Minimizing side effects of systemic corticosteroids in children Indian J. Dermatol. Venereol. Leprol 73 4 2007 218 221 10.4103/0378-6323.33633
36. D.D. Dickerson, A.R. Wolff, and D.K. Bilkey Abnormal long-range neural synchrony in a maternal immune activation animal model of schizophrenia J. Neurosci. 30 37 2010 12424 12431 10.1523/JNEUROSCI.3046-10.2010
37. J. Doorduin, E.F. de Vries, R.A. Dierckx, and H.C. Klein PET imaging of the peripheral benzodiazepine receptor: monitoring disease progression and therapy response in neurodegenerative disorders Curr. Pharm. Des. 14 31 2008 3297 3315
38. F. Doshi-Velez, Y. Ge., and I. Kohane Comorbidity clusters in autism spectrum disorders: an electronic health record time-series analysis Pediatrics 133 1 2014 e54 e63 10.1542/peds.2013-0819
39. C.A. Doyle, C.J. McDougle, and K.A. Stigler Pharmacotherapy of behavioral symptoms and psychiatric comorbidities in adolescents and adults with autism spectrum disorders (chapter 9) F.R. Volkmar, B. Reichow, J.C. McPartland, Adolescents and Adults with Autism Spectrum Disorders pp. 161-191 2014 Springer New York, NY 2014
40. C. Dulac Brain function and chromatin plasticity Nature 465 2010 728 735 10.1038/nature09231
41. C. Edmonson, M.N. Ziats, and O.M. Rennert Altered glial marker expression in autistic post-mortem prefrontal cortex and cerebellum Mol. Autism 5 1 2014 3 10.1186/2040-2392-5-3
42. U.B. Eyo, and L.J. Wu Bidirectional microglia-neuron communication in the healthy brain Neural Plast. 2013 2013 456857 10.1155/2013/456857
43. S.H. Fatemi, J.A. Laurence, M. Araghi-Niknam, J.M. Stary, S.C. Schulz, S. Lee, and I.I. Gottesman Glial fibrillary acidic protein and glutamic acid decarboxylase 65 and 67 kDa proteins are increased in brains of neonatal BALB/c mice following viral infection in utero Schizophr. Res. 69 1 2004 121 123 10.1016/S0920-9964(03)00175-0
44. M.E. Fortier, R. Joober, G.N. Luheshi, and P. Boksa Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring J. Psychiatr. Res. 38 3 2004 335 345 10.1016/j.jpsychires.2003.10.001
45. L. Fung, R.A. Libove, J. Phillips, F. Haddad, and A.Y. Hardan Brief report: an open-label study of the neurosteroid pregnenolone in adults with autism spectrum disorder J. Autism Dev. Disord. 44 11 2014 2971 2977 10.1007/s10803-014-2144-4
46. P.A. Garay, E.Y. Hsiao, P.H. Patterson, and A.K. McAllister Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development Brain Behav. Immun. 31 2013 54 68 10.1016/j.bbi.2012.07.008
47. W. Goldberg, K. Osann, P. Filipek, T. Laulhere, K. Jarvis, C. Modahl, P. Flodman, and M. Spense Language and other regression: assessment and timing J. Autism Dev. Disord. 33 6 2003 607 616 10.1023/B:JADD.0000005998.47370.ef
48. M. Göttlicher Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases Ann. Hematol. 83 Suppl. 1 2004 S91 S92 10.1007/s00277-004-0850-2
49. S. Gupta, B. Rimland, and P.D. Shilling Pentoxifylline: brief review and rationale for its possible use in the treatment of autism J. Child Neurol. 11 6 1996 501 504 10.1177/088307389601100622
50. S. Gupta, S. Aggarwal, and C. Heads Dysregulated immune system in children with autism: beneficial effects of intravenous immune globulin on autistic characteristics J. Autism Dev. Disord. 26 4 1996 439 452 10.1007/BF02172828
51. R.T. Hamza, D.H. Hewedi, and M.A. Ismail Basal and adrenocorticotropic hormone stimulated plasma cortisol levels among Egyptian autistic children: relation to disease severity Ital. J. Pediatr 36 2010 71 10.1186/1824-7288-36-71
52. B.L. Handen, R.D. Melmed, R.L. Hansen, M.G. Aman, D.L. Burnham, J.B. Bruss, and C.J. McDougle A double-blind, placebo-controlled trial of oral human immunoglobulin for gastrointestinal dysfunction in children with autistic disorder J. Autism Dev. Disord. 39 5 2009 796 805 10.1007/s10803-008-0687-y
53. C.S. Hines, M. Fujita, S.S. Zoghibi, J.S. Kim, Z. Quezado, P. Hercovitch, N. Miao, M.D. Ferraris Araneta, C. Morse, V.W. Pike, J. Labovsky, and R.B. Innis Propofol decreases in vivo binding of 11C-PBR28 to translocator protein (18 kDa) in the human brain J. Nucl. Med. 54 1 2013 64 69 10.2967/jnumed.112.106872
54. E.Y. Hsiao, S.W. McBride, J. Chow, S.K. Mazmanian, and P.H. Patterson Modeling an autism risk factor in mice leads to permanent immune dysregulation Proc. Natl. Acad. Sci. U.S.A. 109 31 2012 12776 12781 10.1073/pnas.1202556109
55. V. Hughes Microglia: the constant gardeners Nature 485 7400 2012 570 572 10.1038/485570a
56. H.T. Ito, S.E. Smith, E. Hsiao, and P.H. Patterson Maternal immune activation alters nonspatial information processing in the hippocampus of the adult offspring Brain Behav. Immun. 24 6 2010 930 941 10.1016/j.bbi.2010.03.004
57. K. Iwata, H. Matsuzaki, N. Takei, T. Manabe, and N. Mori Animal models of autism: an epigenetic and environmental viewpoint J. Cent. Nerv. Syst. Dis 2 2010 37 44 10.4137/JCNSD.S6188
58. S. Kannan, F. Saadani-Makki, O. Muzik, P. Chakraborty, T.J. Mangner, J. Janisse, R. Romero, and D.C. Chugani Microglial activation in perinatal rabbit brain induced by intrauterine inflammation: detection with 11C-(R)-PK11195 and small-animal PET J. Nucl. Med. 48 6 2007 946 954 10.2967/jnumed.106.038539
59. L. Kanner Autistic disturbances of affective contact Nerv. Child 2 1943 217 250
60. A. Keil, J.L. Daniels, U. Forssen, C. Hultman, S. Cnattingius, K.C. Söderberg, M. Feycthing, and P. Sparen Parental autoimmune diseases associated with autism spectrum disorders in offspring Epidemiology 21 6 2010 805 808 10.1097/EDE.0b013e3181f26e3f
61. H.A. Kenna, A.W. Poon, C.P. de los Angeles, and L.M. Koran Psychiatric complications of treatment with corticosteroids: review with case report Psychiatry Clin. Neurosci. 65 6 2011 549 560 10.1111/j.1440-1819.2011.02260.x
62. H. Kettenmann, F. Kirchhoff, and A. Verkhratsky Microglia: new roles for the synaptic stripper Neuron 77 1 2013 10 18 10.1016/j.neuron.2012.12.023
63. M. Kimura, L.A. Toth, A.B. Cady, J.A. Maide, and J.M. Krueger Comparison of acute phase responses induced in rabbits by lipopolysaccharide and double-stranded RNA Am. J. Physiol. 267 6 Pt 2 1994 R1596 R1605
64. A. Knudson Mutation and cancer: statistical study of retinoblastoma Proc. Natl. Acad. Sci. U.S.A 68 4 1971 820 823 10.1073/pnas.68.4.820
65. V. Kotla, S. Goel, S. Nischal, C. Heuck, K. Vivek, B. Das, and A. Verma Mechanism of action of lenalidomide in hematological malignancies J. Hematol. Oncol. 2 2009 36 10.1186/1756-8722-2-36
66. 11)C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: implications for positron emission tomographic imaging of this inflammation biomarker NeuroImage 49 4 2010 2924 2932 10.1016/j.neuroimage.2009.11.056
67. W.M. Landau, and F.R. Kleffner Syndrome of acquired aphasia with convulsive disorder in children Neurology 7 1957 523 530 10.1212/01.wnl.0000396605.90704.60
68. C. Lord, M. Rutter, and A. Le Couteur Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders J. Autism Dev. Disord. 24 5 1994 659 685 10.1007/BF02172145
69. C. Lord, S. Risi, L. Lambrecht Jr. , E.H. Cook, B.L. Leventhal, P.C. DiLavore, A. Pickles, and M. Rutter The autism diagnostic observation schedule-generic: a standard measure of social and communicative deficits associated with the spectrum of autism J. Autism Dev. Disord. 30 3 2000 205 223 10.1023/A:1005592401947
70. G.C. Lowe, G.N. Luheshi, and S. Williams Maternal infection and fever during late gestation are associated with altered synaptic transmission in the hippocampus of juvenile offspring rats Am. J. Physiol. Regul. Integr. Comp. Physiol 295 5 2008 R1563 R1571 10.1152/ajpregu.90350.2008
71. M. Makinodan, K. Tatsumi, T. Manave, T. Yamauchi, E. Makinodan, H. Matsuyoshi, S. Shimoda, Y. Noriyama, T. Kishimoto, and A. Wanaka Maternal immune activation in mice delays myelination and axonal development in the hippocampus of the offspring J. Neurosci. Res. 86 10 2008 2190 2200 10.1002/jnr.21673
72. N.V. Malkova, C.Z. Yu, E.Y. Hsiao, M.J. Moore, and P.H. Patterson Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism Brain Behav. Immun. 26 4 2012 607 616 10.1016/j.bbi.2012.01.011
73. M. Mandal, A.C. Marzouk, R. Donnelly, and N.M. Ponzio Maternal immune stimulation during pregnancy affects adaptive immunity in offspring to promote development of TH17 cells Brain Behav. Immun. 25 5 2011 863 871 10.1016/j.bbi.2010.09.011
74. J. Marinović-Curin, I. Marinović-Terzić, Z. Buias-Petković, L. Zekan, V. Skrabić, Z. Dogas, and J. Terzić Slower cortisol response during ACTH stimulation test in autistic children Eur. Child Adolesc. Psychiatry 17 1 2008 39 43 10.1007/s00787-007-0632-1
75. K. Markram, R. Rinaldi, D. La Mendola, C. Sandi, and H. Markram Abnormal fear conditioning and amygdala processing in an animal model of autism Neuropsychopharmacology 33 4 2008 901 912 10.1038/sj.npp.1301453
76. L.A. Martin, P. Ashwood, D. Braunschweig, M. Cabanlit, J. Van de Water, and D.G. Amaral Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism Brain Behav. Immun. 22 6 2008 806 816 10.1016/j.bbi.2007.12.007
77. U. Meyer, M. Nyffeler, A. Engler, A. Urwyler, M. Schedlowski, I. Knuesel, B.K. Yee, and J. Feldon The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology J. Neurosci. 26 18 2006 4752 4762 10.1523/JNEUROSCI.0099-06.2006
78. U. Meyer, P.J. Murray, A. Urwyler, B.K. Yee, M. Schedlowski, and J. Feldon Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling Mol. Psychiatry 13 2 2008 208 221 10.1038/sj.mp.4002042
79. U. Meyer, M. Nyffeker, S. Schwendener, I. Knuesel, B.K. Yee, and J. Feldon Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge Neuropsychopharmacology 33 2 2008 441 456 10.1038/sj.npp.1301413
80. U. Meyer, M. Nyffeler, B.K. Yee, I. Knuesel, and J. Feldon Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice Brain Behav. Immun. 22 4 2008 469 486 10.1016/j.bbi.2007.09.012
81. U. Meyer, E. Spoerri, B.K. Yee, M.J. Schwarz, and J. Feldon Evaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia Schizophr. Bull. 36 3 2010 607 623 10.1093/schbul/sbn131
82. U. Meyer, J. Feldon, and O. Dammann Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation? Pediatr. Res 69 5 Pt 2 2011 26R 33R 10.1203/PDR.0b013e318212c196
83. N. Micali, S. Chakrabarti, and E. Fombonne The broad autism phenotype: findings from an epidemiological survey Autism 8 1 2004 21 37 10.1177/1362361304040636
84. R. Miura, K. Nakamura, A. Miura, K. Hisamatsu, M. Kaliya, S. Nagase, H. Morita, K. Fukushima Kusano, T. Ohe, and K. Ishihara Anti-inflammatory effect of spironolactone on human peripheral blood mononuclear cells J. Pharmacol. Sci. 101 3 2006 256 259 (doi: 10/1254/jphs.SC00600490049)
85. C.A. Molloy, A.L. Morrow, J. Meinzen-Derr, G. Dawson, R. Bernier, M. Dunn, S.L. Hyman, W.M. McMahon, S. Hepburn, N. Minshew, S. Rogers, M. Sigman, M.A. Spence, H. Tager-Flusberg, F.R. Volkmar, and C. Lord Familial autoimmune thyroid disease as a risk factor for regression in children with Autism Spectrum Disorder: a CPEA study J. Autism Dev. Disord. 36 3 2006 317 324 10.1007/s10803-005-0071-0
86. J. Money, N.A. Bobrow, and F.C. Clarke Autism and autoimmune disease: a family study J. Autism Child. Schizophr 1 2 1971 146 160 10.1007/BF01537954
87. S.R. Mordekar, M. Prendergast, A.K. Chattopadhyay, and P.S. Baxter Corticosteroid treatment of behaviour, language and motor regression in childhood disintegrative disorder Eur. J. Paediatr. Neurol. 13 4 2009 367 369 10.1016/j.ejpn.2008.06.001
88. J.T. Morgan, G. Chana, C.A. Pardo, C. Achim, K. Semendeferi, J. Buckwalter, E. Courchesne, and I.P. Everall Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism Biol. Psychiatry 68 4 2010 368 376 10.1016/j.biopsych.2010.05.024
89. J.T. Morgan, G. Chana, I. Abramson, K. Semendeferi, E. Courchesne, and I.P. Everall Abnormal microglial-neuronal spatial organization in the dorsolateral prefrontal cortex in autism Brain Res. 1456 2012 72 81 10.1016/j.brainres.2012.03.036
90. S.H. Mott, S.L. Weinstein, J.A. Conry, L.E. Kenworthy, S. Lockwood, A. Wagner, and R.J. Packer Pervasive developmental disorder/autism versus Landau-Kleffner syndrome: steroid-responsive encephalopathy characterized by language and social interactive impairment Ann. Neurol. 40 2 1996 332
91. S.E. Mouridsen, B. Rich, T. Isager, and N.J. Nedergaard Autoimmune diseases in parents of children with infantile autism: a case-control study Dev. Med. Child Neurol. 49 6 2007 429 432 10.1111/j.1469-8749.2007.00429.x
92. M. Nyffeler, U. Meyer, B.K. Yee, J. Feldon, and I. Knuesel Maternal immune activation during pregnancy increases limbic GABAA receptor immunoreactivity in the adult offspring: implications for schizophrenia Neuroscience 143 1 2006 51 62 10.1016/j.neuroscience.2006.07.029
93. A. Oh-Nishi, S. Obayashi, I. Sugihara, T. Minamimoto, and T. Suhara Maternal immune activation by polyriboinosinic-polyribocytidilic acid injection produces synaptic dysfunction but not neuronal loss in the hippocampus of juvenile rat offspring Brain Res. 1363 2010 170 179 10.1016/j.brainres.2010.09.054
94. C. Onore, M. Careaga, and P. Ashwood The role of immune dysfunction in the pathophysiology of autism Brain Behav. Immun. 26 3 2012 383 392 10.1016/j.bbi.2011.08.007
95. C.E. Onore, J.J. Schwarzer, M. Careaga, R.F. Berman, and P. Ashwood Maternal immune activation leads to activated inflammatory macrophages in offspring Brain Behav. Immun. 38 2014 220 226 10.1016/j.bbi.2014.02.007
96. D.B. Oskvig, A.G. Elkahloun, K.R. Johnson, T.M. Phillips, and M. Herkenham Maternal immune activation by LPS selectively alters specific gene expression profiles of interneuron migration and oxidative stress in the fetus without triggering a fetal immune response Brain Behav. Immun. 26 4 2012 623 634 10.1016/j.bbi.2012.01.015
97. K. Ozawa, and et al. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia Biol. Psychiatry 59 6 2006 546 554 10.1016/j.biopsych.2005.07.031
98. P.H. Patterson Immune involvement in schizophrenia and autism: etiology, pathology and animal models Behav. Brain Res. 204 2 2009 313 321 10.1016/j.bbr.2008.12.016
99. P.H. Patterson Modeling autistic features in animals Pediatr. Res. 69 5 Pt 2 2011 34R 40R 10.1203/PDR.0b013e318212b80f
100. J.M. Petitto, Z. Huang, D. Meola, G.K. Ha, and D. Dauer Interleukin-2 and the septohippocampal system: intrinsic actions and autoimmune processes relevant to neuropsychiatric disorders Methods Mol. Biol. 829 2012 433 443 10.1007/978-1-61779-458-2-27
101. Y. Piontkewitz, Y. Assaf, and I. Weiner Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia Biol. Psychiatry 66 1 2009 1038 1046 10.1016/j.biopsych.2009.07.005
102. A.V. Plioplys Intravenous immunoglobulin treatment of children with autism J. Child Neurol. 13 2 1998 79 82 10.1177/088307389801300207
103. L.C. Politte, C.A. Henry, and C.J. McDougle Psychopharmacological interventions in autism spectrum disorder Harv. Rev. Psychiatry 22 2 2014 76 92 10.1097/HRP.0000000000000030
104. C.V. Portfors Types and functions of ultrasonic vocalizations in laboratory rats and mice J. Am. Assoc. Lab. Anim. Sci. 46 1 2007 28 34
105. T. Rinaldi, G. Silberberg, and H. Markram Hyperconnectivity of local neocortical microcircuitry induced by prenatal exposure to valproic acid Cerebral Cortex 18 4 2008 763 770 10.1093/cercor/bhm117
106. J.I. Rodriguez, and J.K. Kern Evidence of microglial activation in autism and its possible role in brain underconnectivity Neuron Glia Biol. 7 2-4 2011 205 213 10.1017/S1740925X12000142
107. F. Ros-Bernal, S. Hunot, M.T. Herrero, S. Parnadeau, J.C. Corvol, L. Lu, D. Alvarez-Fischer, M.A. Carrillo-de Sauvage, F. Saurini, C. Coussieu, K. Kiugawa, A. Prigent, G. Höglinger, M. Hamon, F. Tronche, E.C. Hirsch, and S. Vyas Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism Proc. Natl. Acad. Sci. U.S.A 108 16 2011 6632 6637 10.1073/pnas.1017820108
108. M.L. Scattoni, S.U. Gandhy, L. Ricceri, and J.N. Crawley Unusual repertoire of vocalizations in the BTBR T+tf/J mouse model of autism PLoS One 3 8 2008 e3067 10.1371/journal.pone.0003067
109. D.P. Schafer, E.K. Lehrman, A.G. Kautzman, R. Koyama, A.R. Mardinly, R. Yamasaki, R.M. Ransohoff, M.E. Greenberg, B.A. Barres, and B. Stevens Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner Neuron 74 4 2012 691 705 10.1016/j.neuron.2012.03.026
110. C.K. Schneider, R.D. Melmed, L.E. Barstow, F.J. Enriquez, J. Ranger-Moore, and J.A. Ostrem Oral human immunoglobulin for children with autism and gastrointestinal dysfunction: a prospective, open-label study J. Autism Dev. Disord. 36 8 2006 1053 1064 10.1007/s10803-006-0141-y
111. T. Schneider, and R. Przewlocki Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism Neuropsychopharmacology 30 1 2005 80 89 10.1038/sj.npp.1300518
112. T. Schneider, A. Roman, A. Basta-Kaim, M. Kubera, B. Budziszewska, K. Schneider, and R. Przewlocki Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid Psychoneuroendocrinology 33 6 2008 728 740 10.1016/j.psyneuen.2008.02.011
113. E. Schwarz, P.C. Guest, H. Rahmoune, L. Wang, Y. Levin, E. Ingudomnukul, L. Ruta, L. Kent, M. Spain, S. Baron-Cohen, and S. Bahn Sex-specific serum biomarker patterns in adults with Asperger's syndrome Mol. Psychiatry 16 12 2011 1213 1220 10.1038/mp.2010.102
114. N. Schweingruber, S.D. Reichardt, F. Lühder, and H.M. Reichardt Mechanisms of glucocorticoids in the control of neuroinflammation J. Neuroendocrinol. 24 1 2012 174 182 10.1111/j.1365-2826.2011.02161.x
115. S. Shenoy, S. Arnold, and T. Chatila Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome J. Pediatr. 136 5 2000 682 687 10.1067/mpd.2000.105355
116. L. Shi, S.H. Fatemi, R.W. Sidwell, and P.H. Patterson Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring J. Neurosci. 23 1 2003 297 302 10.1523/JNEUROSCI.4230-10.2011
117. L. Shi, S.E. Smith, N. Malkova, D. Tse, Y. Su, and P.H. Patterson Activation of the maternal immune system alters cerebellar development in the offspring Brain Behav. Immun. 23 1 2009 116 123 10.1016/j.bbi.2008.07.012
118. H.S. Singer, C. Morris, C. Gause, M. Pollard, A.W. Zimmerman, and M. Pletnikov Prenatal exposure to antibodies from mothers of children with autism produces neurobehavioral alterations: a pregnant dam mouse model J. Neuroimmunol. 211 1-2 2009 39 48 10.1016/j.jneuroim.2009.03.011
119. S.E. Smith, J. Li, K. Garbett, K. Mirnics, and P.H. Patterson Maternal immune activation alters fetal brain development through interleukin-6 J. Neurosci. 27 40 2007 10695 10702 10.1523/JNEUROSCI.2178-07.2007
120. M.W. State, and P. Levitt The conundrums of understanding genetic risks for autism spectrum disorders Nat. Neurosci. 14 2011 1499 1506 10.1038/nn.2924
121. H. Steeb, J.M. Ramsey, P.C. Guest, P. Stocki, J.D. Cooper, H. Rahmoune, E. Ingudomnukul, B. Auyeung, L. Ruta, S. Baron-Cohen, and S. Bahn Serum proteomic analysis identifies sex-specific differences in lipid metabolism and inflammation profiles in adults diagnosed with Asperger syndrome Mol. Autism 5 1 2014 4 10.1186/2040-2392-5-4
122. G.A. Stefanatos, W. Grover, and E. Geller Case study: corticosteroid treatment of language regression in pervasive developmental disorder J. Am. Acad. Child Adolesc. Psychiatry 34 8 1995 1107 1111 10.1097/00004583-199508000-00022
123. K.A. Stigler, T.L. Sweeten, D.J. Posey, and C.J. McDougle Autism and immune factors: a comprehensive review Res. Autism Spectr. Disord. 3 4 2009 840 860 10.1016/j.rasd.2009.01.007
124. R. Stoner, M.L. Chow, M.P. Boyle, S.M. Sunkin, P.R. Mouton, S. Roy, A. Wynshaw-Boris, S.A. Colamarino, E.S. Lein, and E. Courchesne Patches of disorganization in the neocortex of children with autism NEJM 370 2014 1209 1219 10.1056/NEJMoa1307491
125. K. Suzuki, G. Sugihara, Y. Ouchi, K. Nakamura, M. Futatsubashi, K. Takebayashi, Y. Yoshihara, K. Omata, K. Matsumoto, K. Tsuchiya, Y. Iwata, M. Tsujii, T. Sugiyama, and N. Mori Microglial activation in young adults with autism spectrum disorders JAMA Psychiatry 70 1 2013 49 58 10.1001/jamapsychiatry.2013.272
126. T.L. Sweeten, S.L. Bowyer, D.J. Posey, G.M. Halberstadt, and C.J. McDougle Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders Pediatrics 112 5 2003 e420 10.1542/peds.112.5.e420
127. M.E. Talkowski, E.V. Minikel, and J.F. Gusella Autism spectrum disorder genetics: diverse genes with diverse clinical outcomes Harv. Rev. Psychiatry 22 2 2014 65 75 10.1097/HRP.0000000000000002
128. N.A. Tetreault, A.Y. Hakeem, S. Jiang, B.A. Williams, E. Allman, B.J. Wold, and J.M. Allman Microglia in the cerebral cortex in autism J. Autism Dev. Disord. 42 2012 2569 2584
129. Z. Tobiasova, K.H. van der Lingen, L. Scahill, J.F. Leckman, Y. Zhang, W. Chae, J.T. McCracken, C.J. McDougle, B. Vitiello, E. Tierney, M.G. Aman, L.E. Arnold, L. Katsovich, P.J. Hoekstra, F. Volkmar, A.L. Bothwell, and I. Kawikova Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13 J. Child Adolesc. Psychopharmacol 21 6 2011 555 564 10.1089/cap.2010.0134
130. T.R. Traynor, J.A. Maide, S.G. Bohnet, and J.M. Krueger Intratracheal double-stranded RNA plus interferon-gamma: a model for analysis of the acute phase response to respiratory viral infections Life Sci. 74 20 2004 2563 2576 (doi: 10.1016.j.lfs.2003.10.010)
131. R.F. Tuchman, I. Rapin, and S. Shinnar Regression in pervasive developmental disorders: seizures adn epileptiform EEG correlates Pediatrics 99 1997 560 566 10.1542/peds.99.4.560
132. T. Van Gent, C.J. Heijnen, and P.D. Treffers Autism and the immune system J. Child Psychol. Psychiatry 38 3 1997 337 349
133. D.L. Vargas, C. Nascimbene, C. Krishnan, A.W. Zimmerman, and C.A. Pardo Neuroglial activation and neuroinflammation in the brain of patients with autism Ann. Neurol. 57 1 2005 67 81 10.1002/ana.20315
134. S. Venneti, B.J. Lopresti, and C.A. Wiley The peripheral benzodiazepine receptor (translocator protein 18 kDa) in microglia: from pathology to imaging Prog. Neurobiol. 80 6 2006 308 322 10.1016/j.pneurobio.2006.10.002
135. A.W. Zimmerman, H. Jyonouchi, A.M. Comi, S.L. Connors, S. Milstien, A. Varsou, and M.P. Heyes Cerebrospinal fluid and serum markers of inflammation in autism Pediatr. Neurol. 33 3 2005 195 201 10.1016/j.pediatrneurol.2005.03.014
136. L. Zuckerman, M. Rehavi, R. Nachman, and I. Weiner Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia Neuropsychopharmacology 28 10 2003 1778 1789 10.1038/sj.npp.1300248
137. L. Zuckerman, and I. Weiner Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring J. Psychiatr. Res. 39 3 2005 311 323 10.1016/j.jpsychires.2004.08.008